You have 9 free searches left this month | to do more
Showing 1 - 25 of
1,652 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
  • Acute Myeloid Leukemia
  • Cytarabine
  • Gainesville, Florida
    University of Florida
2022-03-15
Mar 15, 2022
C
Recruiting
  • Acute Myeloid Leukemia
  • Daunorubicin Cytarabine liposome for injection
  • Vyxeos、Daunorubicin Cytarabine liposome for injection
  • Tianjin, China
    Institute of Hematology and Hospital of Blood Disease, Chinese A
2021-06-07
Jun 7, 2021
T
Not yet recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • HYML-122; cytarabine
  • (no location specified)
2022-02-06
Feb 6, 2022
T
Terminated
  • Minimal Residual Disease
  • +2 more
  • Charlotte, North Carolina
  • +1 more
2021-10-04
Oct 4, 2021
H
Active, not recruiting
  • Leukemia
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-11-15
Nov 15, 2021
M
Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Liposomal Annamycin
  • Cytarabine
  • Poznań, Poland
    Szpital Kliniczny Przemienienia Pańskiego Uniwersytetu Medyczneg
2022-04-05
Apr 5, 2022
w
Recruiting
  • CEBPA Double Mutation
  • Acute Myeloid Leukemia
  • HAD induction with intermediate dose cytarabine
  • Tianjin, Tianjin, China
    HBDH
2021-08-05
Aug 5, 2021
J
Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • Miami, Florida
    University of Miami
2021-12-07
Dec 7, 2021
W
Active, not recruiting
  • Mantle Cell Lymphoma
  • Saint Louis, Missouri
    Washington University School of Medicine
2022-02-02
Feb 2, 2022
U
Terminated
  • Acute Myeloid Leukemia
  • Cytarabine
  • +2 more
  • Chicago, Illinois
    University of Illinois at Chicago
2021-07-01
Jul 1, 2021
C
Not yet recruiting
  • Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • Mitoxantrone Hydrochloride liposome injection
  • Cytarabine (LoDAC)
  • Guiyang, Guizhou, China
    The Affiliated Hospital of Guizhou Medical University
2021-10-19
Oct 19, 2021
M
Recruiting
  • Leukemia, Myeloid, Acute
  • Milwaukee, Wisconsin
    Froedtert Hospital
2021-05-24
May 24, 2021
W
Active, not recruiting
  • Mantle Cell Lymphoma
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-05-21
May 21, 2021
P
Recruiting
  • Acute Leukemia
  • Tampa, Florida
  • +1 more
2021-02-08
Feb 8, 2021
P
Recruiting
  • Langerhans Cell Histiocytosis
  • Cytarabine
  • Beijing, China
    Peking Union Medical College Hospital
2021-06-07
Jun 7, 2021
C
Recruiting
  • Refractory Acute Myeloid Leukemia
  • Recurrent Acute Myeloid Leukemia
  • Kansas City, Kansas
    University of Kansas Medical Center
2021-10-12
Oct 12, 2021
M
Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Cytarabine
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-01
Mar 1, 2022
M
Recruiting
  • Acute Myeloid Leukemia
  • Cytarabine
  • +5 more
  • Duarte, California
  • +2 more
2022-01-21
Jan 21, 2022
B
Recruiting
  • Langerhans Cell Histiocytosis
  • San Diego, California
  • +4 more
2021-06-02
Jun 2, 2021
M
Recruiting
  • Secondary Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
2021-06-25
Jun 25, 2021
F
Recruiting
  • Acute Myeloid Leukemia
  • Myeloid Neoplasm
  • Liposome-encapsulated Daunorubicin-Cytarabine
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-15
Mar 15, 2022
M
Recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +3 more
  • Gemtuzumab Ozogamicin
  • Liposome-encapsulated Daunorubicin-Cytarabine
  • Houston, Texas
    M D Anderson Cancer Center
2021-06-02
Jun 2, 2021